LONDON, February 4 /PRNewswire-FirstCall/ -- Amarin Corporation plc (NASDAQ: AMRND) today announced that its Board of Directors has established the position of Lead Independent Director and has appointed current board member, Dr. William Mason, to that role. In his capacity as Lead Independent Director, Dr. Mason will have the authority to convene meetings of the independent directors, and will preside over those meetings, will coordinate the activities of the independent directors, and will act as a liaison between the independent directors, the Board and the Chairman.
The establishment of a Lead Independent Director and Dr. Mason's appointment to that position follows the recent announcement by Amarin that Thomas Lynch, Amarin's Chairman, has assumed the additional role of Chief Executive Officer of Amarin.
Mr. Lynch commented, "Dr. Mason's appointment as our Lead Independent Director reflects our ongoing commitment to maintaining high standards of corporate governance. Dr. Mason is a valued non-executive board member, and an experienced advisor to the pharmaceutical and biotechnology industry. We look forward to his continued contribution to our business."
Dr. Mason added, "I am pleased to accept the new role of Lead Independent Director and look forward to working with both Amarin's talented resource of independent directors, as well as with Thomas Lynch, our experienced Chairman and CEO, at what is a very exciting time for the Company. This is a valuable step in the evolution of our high standards of governance. Amarin's Board of Directors is committed to the highest level of corporate governance in our quest to achieve value for all of our shareholders."
Dr. Mason has served as a non-executive board memb
|SOURCE Amarin Corporation Plc|
Copyright©2008 PR Newswire.
All rights reserved